References |
1. |
Alland, L.,
R. Muhle,
H.J. Hou,
J. Potes,
L. Chin,
N. Schreiber‐Agus, and
R. A DePinho.
Role for N‐CoR and his tone deacetylase in Sin3‐mediated transcriptional repression.
Nature
387:
49–55,
1997.
|
2. |
Arnold, S. F.,
D. P. Vorojeikina, and
A. C. Notides.
Phosphorylation of tyrosine 537 on the human estrogen receptor is required for binding to an estrogen response element.
J. Biol. Chem.
270:
30205–30212,
1995.
|
3. |
Au‐Fliegner, M.,
E. Helmer,
J. Casanova,
B. M. Raaka, and
H. H. Samuels.
The conserved ninth C‐terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation.
Mol. Cell. Biol.
13:
5725–5737,
1993.
|
4. |
Barker, S. B., and
H. M. Klitgaard.
Metabolism of tissues excised from the thyroxine‐injected rats.
Am. J. Physiol.
170:
81–86,
1952.
|
5. |
Berry, M. J.,
L. Banu, and
P. R. Larsen.
Type I iodothyronine deiodinase is a selenocysteine‐containing enzyme.
Nature
349:
438–440,
1991.
|
6. |
Bhat, M. K.,
K. Ashizawa, and
S. Cheng.
Phosphorylation enhances the target gene sequence‐dependent dimerization of thyroid hormone receptor with retinoid X receptor.
Proc. Natl. Acad. Sci. USA
91:
7927–7931,
1994.
|
7. |
Bigler, J., and
R. N. Eisenman.
Novel location and function of a thyroid hormone response element.
EMBO J.
14:
5710–5723,
1995.
|
8. |
Bodenner, D. L.,
M. A. Mroczynski,
B. D. Weintraub,
S. Radovick, and
F. E. Wondisford.
A detailed functional and structural analysis of a major thyroid hormone inhibitory element in the human thyrotropin beta‐subunit gene.
J. Biol. Chem.
266:
21666–21673,
1991.
|
9. |
Bogazzi, F.,
L. D. Hudson, and
V. M. Nikodem.
A novel heterodimerization partner for thyroid hormone receptor. Peroxisome proliferator‐activated receptor.
J. Biol. Chem.
269:
11683–11686,
1994.
|
10. |
Boucher, P.,
A. Koning, and
M. L. Privalsky.
The avian erythroblastosis virus erbA oncogene encodes a DNA‐binding protein exhibiting distinct nuclear and cytoplasmic subcellar localizations.
J. Virol.
62:
534–544,
1988.
|
11. |
Bourguet, W.,
M. Ruff,
P. Chambon,
H. Gronemeyer, and
D. Moras.
Crystal structure of the ligand‐binding domain of the human nuclear receptor RXR‐alpha.
Nature
375:
377–360,
1995.
|
12. |
Bradley, D.,
H. Towle, and
W. Young III.
Spatial and temporal expression of α‐and β‐thyroid hormone receptor mRNAs, including the β2‐subtype, in the developing mammalian nervous system.
J. Neurosci.
12:
2288–2302,
1992.
|
13. |
Brent, G. A.,
M. K. Dunn,
J. W. Harney,
T. Gulick,
P. R. Larsen, and
D. D. Moore.
Thyroid hormone aporeceptor represses T3‐inducible promoters and blocks activity of the retinoic acid receptor.
The New Biologist
1:
329–336,
1989.
|
14. |
Brent, G. A.,
G. R. Williams,
J. W. Harney,
B. M. Forman,
H. H. Samuels,
D. D. Moore, and
P. R. Larsen.
Effects of varying the position of thyroid hormone response elements within the rat growth hormone promoter: implications for positive and negative regulation by 3,5,3′‐triiodothyronine.
Mol. Endocrinol.
5:
542–548,
1991.
|
15. |
Brucker‐Davis, F.,
M. C. Skarulis,
M. B. Grace,
J. Benichou,
P. Hauser,
E. Wiggs, and
B. D. Weintraub.
Genetic and clinical features of 42 kindreds with resistance to thyroid hormone—The National Institutes of Health Prospective Study.
Ann. Intern. Med.
123:
572–583,
1995.
|
16. |
Carr, F. E., and
N.C.W. Wong.
Characteristics of a negative thyroid hormone response element.
J. Biol. Chem.
269:
4175–4179,
1994.
|
17. |
Casanova, J.,
Z. D. Horowitz,
R. P. Copp,
W. R. McIntyre,
A. Pascual, and
H. H. Samuels.
Photoaffinity labeling of thyroid hormone nuclear receptors.
J. Biol. Chem.
259:
12084–12091,
1984.
|
18. |
Cavaillès, V.,
S. Cauvois,
F. L'Horset,
G. Lopez,
S. Hoare,
P. J. Kushner, and
M. G. Parker.
Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor.
EMBO J.
14:
3741–3751,
1995.
|
19. |
Chen, J. D., and
R. M. Evans.
A transcriptional co‐repressor that interacts with nuclear hormone receptors.
Nature
377:
454–457,
1995.
|
20. |
Chrivia, J. C.,
R.P.S. Kwok,
N. Lamb,
M. Hagiwara,
M. R. Montminy, and
R. H. Goodman.
Phosphorylated CREB binds specifically to the nuclear protein CBP.
Nature
365:
855–859,
1993.
|
21. |
Cook, C. B., and
R. J. Koenig.
Expression of erbAα and β mRNAs in regions of adult rat brain.
Mol. Cell. Endocrinol.
70:
13–20,
1990.
|
22. |
Cook, C. B.,
R. M. Lechan, and
R.J. Koenig.
Expression of thyroid hormone receptor β2 in rat hypothalamus.
Endocrinology
130:
1077–1079,
1992.
|
23. |
Dai, G.,
O. Levy, and
N. Carrasco.
Cloning and characterization of the thyroid iodide transporter.
Nature
379:
458–460,
1996.
|
24. |
Damm, K.,
C. C. Thompson, and
R. M. Evans.
Protein encoded by v‐erbA functions as a thyroid hormone receptor antagonist.
Nature
339:
593–597,
1989.
|
25. |
Dang, C. V., and
W. M. F. Lee.
Nuclear and nucleolar targeting sequences of c‐erb‐A, c‐myb, N‐myc, p53, HSP70, and HIV tat proteins.
J. Biol. Chem.
264:
18019–18023,
1989.
|
26. |
Danielian, P. S.,
R. White,
J. A. Lees, and
M. G. Parker.
Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors.
EMBO J.
11:
1025–1033,
1992.
|
27. |
Davey, J. C.,
K. B. Becker,
M. J. Schneider,
D. L. St. Germain, and
V. A. Galton.
Cloning of a cDNA for the type II iodothyronine deiodinase.
J. Biol. Chem.
270:
26786–26789,
1995.
|
28. |
Debuire, B.,
C. Henry,
M. Benaissa,
G. Biserte,
J. M. Claverie,
S. Saule,
P. Martin, and
D. Stehelin.
Sequencing the erbA gene of avian erythroblastosis virus reveals a new type of oncogene.
Science
224:
1456–1459,
1984.
|
29. |
Dreyer, C.,
G. Krey,
H. Keller,
F. Givel,
G. Helftenbein, and
W. Wahli.
Control of the peroxisomal beta‐oxidation pathway by a novel family of nuclear hormone receptors.
Cell
68:
879–887,
1992.
|
30. |
Edwards, J. G.,
J. J. Bahl,
I. L. Flink,
S.‐ Y. Cheng, and
E. Morkin.
Thyroid hormone influences beta myosin heavy chain (betaMHC) expression.
Biochem. Biophys. Res. Commun.
199:
1482–1488,
1994.
|
31. |
Farsetti, A.,
B. Desvergne,
P. Hallenbeck,
J. Robbins, and
V. M. Nikodem.
Characterization of myelin basic protein thyroid hormone response element and its function in the context of native and heterologous promoter.
J. Biol. Chem.
267:
15784–15788,
1992.
|
32. |
Fondell, J. D.,
F. Brunei,
K. Hisatake, and
R. G. Roeder.
Unliganded thyroid hormone receptor alpha can target TATA‐Binding protein for transcriptional repression.
Mol. Cell. Biol.
16:
281–287,
1996.
|
33. |
Forman, B. M., and
H. H. Samuels.
Interactions among a subfamily of nuclear hormone receptors: the regulatory zipper model.
Mol. Endocrinol.
4:
1293–1301,
1990.
|
34. |
Forman, B. M.,
P. Tontonoz,
J. Chen,
R. P. Brun,
B. M. Spiegelman, and
R. M. Evans.
15‐deoxy‐delta 12,14‐prostaglandin J2 is a ligand for the adipocyte determination factor PPAR‐gamma.
Cell
83:
803–812,
1995.
|
35. |
Forrest, D.,
L. C. Erway,
L. Ng,
R. Altschuler, and
T. Curran.
Thyroid hormone receptor beta is essential for development of auditory function.
Nat. Genet.
13:
354–357,
1996.
|
36. |
Forrest, D.,
E. Hanebuth,
R. J. Smeyne,
N. Everds,
C. L. Stewart,
J. M. Wehner, and
T. Curran.
Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor beta: Evidence for tissue‐specific modulation of receptor function.
EMBO J.
15:
3006–3015,
1996.
|
37. |
Forrest, D.,
M. Sjoberg, and
B. Vennstrom.
Contrasting devel opmental and tissue‐specific expression of α and β thyroid hormone receptor genes.
EMBO J.
9:
1519–1528,
1990.
|
38. |
Fraichard, A.,
O. Chassande,
M. Plateroti,
J. P. Roux,
J. Trouillas,
C. Dehay,
C. Legrand,
K. Gauthier,
M. Kedinger,
L. Malaval,
B. Rousset, and
J. Samarut.
The T3Rα gene encoding a thyroid hormone receptor is essential for post‐natal development and thyroid hormone production.
EMBO J.
16:
4412–4420,
1997.
|
39. |
Frykberg, L.,
S. Palmieri,
H. Beug,
T. Graf,
M. J. Hayman, and
B. Vennstrom.
Transforming capacities of avian erythroblastosis virus mutants deleted in the erbA or erbB oncogenes.
Cell
32:
227–238,
1983.
|
40. |
Gandrillon, O.,
P. Jurdic,
B. Pain,
C. Desbois,
J. J. Madjar,
M. G. Moscovici,
C. Moscovici, and
J. Samarut.
Expression of the v‐erbA product, an altered nuclear hormone receptor, is sufficient to transform erythrocytic cells in vitro.
Cell
58:
115–121,
1989.
|
41. |
Gearing, K. L.,
M. Göttlicher,
M. Teboul,
E. Widmark, and
J.‐ Å. Gustafsson.
Interaction of the peroxisome‐proliferator‐activated receptor and retinoid X receptor.
Proc. Natl. Acad. Sci. USA
90:
1440–1444,
1993.
|
42. |
Glass, C. K.,
R. Franco,
C. Weinberger,
V. R. Albert,
R. M. Evans, and
M. G. Rosenfeld.
A c‐erbA binding site in rat growth hormone gene mediates trans‐activation by thyroid hormone.
Nature
329:
738–741,
1987.
|
43. |
Glass, C. K.,
J. M. Holloway,
O. V. Devary, and
M. G. Rosenfeld.
The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements.
Cell
54:
313–323,
1988.
|
44. |
Glass, C. K.,
S. M. Lipkin,
O. V. Devary, and
M. G. Rosenfeld.
Positive and negative regulation of gene transcription by a retinoic acid‐thyroid hormone receptor heterodimer.
Cell
59:
697–708,
1989.
|
45. |
Graf, T., and
H. Beug.
Avian leukemia viruses: interaction with their target cells in vivo and in vitro.
Biochim. Biophys. Acta
516:
269–299,
1978.
|
46. |
Graves, R. J.
Clinical lectures delivered by Robert J. Graves, M.D., at the Meath Hospital during the session of 1834–5.
London Med. Surg. J.
7:
516,
1835.
|
47. |
Gross, J., and
R. Pitt‐Rivers.
The identification of 3,5,3′‐l‐triiodothyronine in human plasma.
Lancet
1:
439–441,
1952.
|
48. |
Gross, J., and
R. Pitt‐Rivers.
Physiological activity of 3,5,3′ L‐triiodothyronine.
Lancet
1:
593–594,
1952.
|
49. |
Harington, C. R.
Chemistry of thyroxine. I. Isolation of thyroxine from the thyroid gland.
Biochem. J.
20:
293–299,
1926.
|
50. |
Harington, C. R., and
G. Barger.
Chemistry of thyroxine. III. Constitution and synthesis of thyroxine.
Biochem. J.
21:
169–183,
1927.
|
51. |
Hassig, C. A.,
T. C. Fleischer,
A. N. Billin,
S. L. Schreiber, and
D. E. Ayer.
Histone deacetylase activity is required for full transcriptional repression by mSin3A.
Cell
89:
341–347,
1997.
|
52. |
Heyman, R. A.,
D. J. Mangelsdorf,
J. A. Dyck,
R. B. Stein,
G. Eichele,
R. M. Evans, and
C. Thaller.
9–cis retinoic acid is a high affinity ligand for the retinoid‐X receptor.
Cell
68:
397–406,
1992.
|
53. |
Hodin, R. A.,
M. A. Lazar,
B. I. Wintman,
D. S. Darling,
R. J. Koenig,
P. R. Larsen,
D. D. Moore, and
W. W. Chin.
Identification of a thyroid hormone receptor that is pituitary specific.
Science
244:
76–79,
1989.
|
54. |
Hollenberg, A. N.,
T. Monden,
T. R. Flynn,
M.‐ E. Boers,
O. Cohen, and
F. E. Wondisford.
The human thyrotropin‐releasing hormone gene is regulated by thyroid hormone through two distinct classes of negative thyroid hormone response elements.
Mol. Endocrinol.
9:
540–550,
1995.
|
55. |
Hong, S. H.,
G. David,
C. W. Wong,
A. Dejean, and
M. L. Privalsky.
SMRT corepressor interacts with PLZF and with the PML‐retinoic acid receptor alpha (RARa) and PLZF‐RARa oncoproteins associated with acute promyelocytic leukemia.
Proc. Natl. Acad. Sci. USA
94:
9028–9033,
1997.
|
56. |
Hörlein, A. J.,
A. M. Näär,
T. Heinzel,
J. Torchia,
B. Gloss,
R. Kurokawa,
A. Ryan,
Y. Kamel,
M. Söderström,
C. K. Glass, and
M. G. Rosenfeld.
Ligand‐independent repression by the thyroid hormone receptor mediated by a nuclear receptor corepressor.
Nature
377:
397–404,
1995.
|
57. |
Hsieh, J. C.,
P. W. Jurutka,
M. A. Galligan,
C. M. Terpening,
C. A. Haussler,
D. S. Samuels,
Y. Shimizu,
N. Shimizu, and
M. R. Haussler.
Human vitamin‐D receptor is selectively phosphorylated by protein kinase‐C on serine‐51, a residue crucial to its trans‐activation function.
Proc. Natl. Acad. Sci. USA
88:
9315–9319,
1991.
|
58. |
Issemann, I., and
S. Green.
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.
Nature
347:
645–650,
1990.
|
59. |
Jackson, T. A.,
J. K. Richer,
D. L. Bain,
G. S. Takimoto,
L. Tung, and
K. B. Horwitz.
The partial agonist activity of antagonist‐occupied steroid receptors is controlled by a novel hinge domain‐binding coactivator L7/SPA and the corepressors N‐CoR or SMRT.
Mol. Endocrinol.
11:
693–705,
1997.
|
60. |
Kamei, Y.,
L. Xu,
T. Heinzel,
J. Torchia,
R. Kurokawa,
B. Gloss,
S. Lin,
R. A. Heyman,
D. W. Rose,
C. K. Glass, and
M. G. Rosenfeld.
A CBP integrator complex mediates transcriptional activation and AP‐1 inhibition by nuclear receptors.
Cell
85:
403–414,
1996.
|
61. |
Kato, S.,
H. Endoh,
Y. Masuhiro,
T. Kitamoto,
S. Uchiyama,
H. Sasaki,
S. Masushige,
Y. Gotoh,
E. Nishida,
H. Kawashima,
D. Metzger, and
P. Chambon.
Activation of the estrogen receptor through phosphorylation by mitogen‐activated protein kinase.
Science
270:
1491–1494,
1995.
|
62. |
Katz, R. W., and
R. J. Koenig.
Non‐biased identification of DNA sequences which bind thyroid hormone receptor α1 with high affinity.
J. Biol. Chem.
268:
19392–19397,
1993.
|
63. |
Katz, R. W., and
R. J. Koenig.
Specificity and mechanism of thyroid hormone induction from an octamer response element.
J. Biol. Chem.
269:
18915–18920,
1994.
|
64. |
Katz, D.,
M. J. Reginato, and
M. A. Lazar.
Functional regulation of thyroid hormone receptor variant TRα2 by phosphorylation.
Mol. Cell. Biol.
15:
2341–2348,
1995.
|
65. |
Kendall, E. C.
The isolation in crystalline form of the compound containing iodine which occurs in the thyroid: its chemical nature and physiological activity.
Trans. Assoc. Am. Physicians
30:
420–449,
1915.
|
66. |
Kim, S. W.,
I. M. Ahn, and
P. R. Larsen.
In vivo genomic foot‐printing of thyroid hormone‐responsive genes in pituitary tumor cell lines.
Mol. Cell. Biol.
16:
4465–4477,
1996.
|
67. |
Kliewer, S. A.,
J. M. Lenhard,
T. M. Willson,
I. Patel,
D. C. Morris, and
J. M. Lehmann.
A prostaglandin J2 metabolite binds peroxisome proliferator‐activated receptor gamma and promotes adipocyte differentiation.
Cell
83:
813–819,
1995.
|
68. |
Kliewer, S. A.,
K. Umesono,
D. J. Mangelsdorf, and
R. M. Evans.
Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling.
Nature
355:
446–449,
1992.
|
69. |
Kocher, T.
Ueber Kropfsextirpation und ihre Folgen.
Arch. Klin. Chir.
29:
254,
1883.
|
70. |
Koenig, R. J.,
G. A. Brent,
R. L. Warne,
P. R. Larsen, and
D. D. Moore.
Thyroid hormone receptor binds to a site in the rat growth hormone promoter required for induction by thyroid hormone.
Proc. Natl. Acad. Sci. USA
84:
5670–5674,
1987.
|
71. |
Koenig, R. J.,
M. A. Lazar,
R. A. Hodin,
G. A. Brent,
P. R. Larsen,
W. W. Chin, and
D. D. Moore.
Inhibition of thyroid hormone action by a non‐hormone binding c‐erbA protein generated by alternative mRNA splicing.
Nature
337:
659–661,
1989.
|
72. |
Koenig, R. J.,
R. L. Warne,
G. A. Brent,
J. W. Harney,
P. R. Larsen, and
D. D. Moore.
Isolation of a cDNA clone encoding a biologically active thyroid hormone receptor.
Proc. Natl. Acad. Sci. USA
85:
5031–5035,
1988.
|
73. |
Kurokawa, R.,
V. C. Yu,
A. Näär,
S. Kyakumoto,
Z. Han,
S. Silverman,
M. G. Rosenfeld, and
C. K. Glass.
Differential orientations of the DNA‐binding domain and carboxy‐terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers.
Genes Dev.
7:
1423–1435,
1993.
|
74. |
Laudet, V.,
A. Begue,
C. Henry‐Duthoit,
A. Joubel,
P. Martin,
D. Stehelin, and
S. Saule.
Genomic organization of the human thyroid hormone receptor α (c‐erb A‐1) gene.
Nucleic Acids Res.
19:
1105–1112,
1991.
|
75. |
Lee, J. W.,
H.‐ S. Choi,
J. Gyuris,
R. Brent, and
D. D. Moore.
Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor.
Mol. Endocrinol.
9:
243–254,
1995.
|
76. |
Lee, J. W.,
T. Gulick, and
D. D. Moore.
Thyroid hormone receptor dimerization function maps to a conserved subregion of the ligand binding domain.
Mol. Endocrinol.
6:
1867–73,
1992.
|
77. |
Lee, J. W.,
F. Ryan,
J. C. Swaffield,
S. A. Johnston, and
D. D. Moore.
Interaction of thyroid‐hormone receptor with a conserved transcriptional mediator.
Nature
374:
91–94,
1995.
|
78. |
Lee, L.‐ R.,
R. M. Mortensen,
C. A. Larson, and
G. A. Brent.
Thyroid hormone receptor‐alpha inhibits retinoic acid‐responsive gene expression and modulates retinoic acid‐stimulated neural differentiation in mouse embryonic stem cells.
Mol. Endocrinol.
8:
746–756,
1994.
|
79. |
Lee, Y., and
V. Mahdavi.
The D domain of the thyroid hormone receptor α1 specifies positive and negative transcriptional regulation functions.
J. Biol. Chem.
268:
2021–2028,
1993.
|
80. |
Lehmann, J. M.,
L. B. Moore,
T. A. Smith‐Oliver,
W. O. Wilkison,
T. M. Willson, and
S. A. Kliewer.
An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator‐activated receptor γ (PPARγ).
J. Biol. Chem.
270:
12953–12956,
1995.
|
81. |
Leid, M.,
P. Kastner,
R. Lyons,
H. Nakshatri,
M. Saunders,
T. Zacharewski,
J. Y. Chen,
A. Staub,
J. M. Gamier,
S. Mader, and
P. Chambon.
Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently.
Cell
68:
377–395,
1992.
|
82. |
Levin, A. A.,
L. J. Sturzenbecker,
S. Kazmer,
T. Bosakowski,
C. Huselton,
G. Allenby,
J. Speck,
C. Kratzeisen,
M. Rosenberger,
A. Lovey, and
J. F. Grippo.
9‐cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRa.
Nature
355:
359–361,
1992.
|
83. |
Lin, K.,
K. Ashizawa, and
S. Cheng.
Phosphorylation stimulates the transcriptional activity of the human β1 thyroid hormone nuclear receptor.
Proc. Natl. Acad. Sci. USA
89:
7737–7741,
1992.
|
84. |
Mangelsdorf, D. J.,
C. Thummel,
M. Beato,
P. Herrlich,
G. Schütz,
K. Umesono,
B. Blumberg,
P. Kastner,
M. Mark,
P. Chambon, and
R. M. Evans.
The nuclear receptor superfamily: the second decade.
Cell
83:
835–839,
1995.
|
85. |
Mann, D. N.,
M. H. Kumara‐Siri, and
M. I. Surks.
Effect of 5,5′‐diphenylhydantoin on the activities of hepatic cytosol malic enzyme and mitochondrial α‐glycerophosphate dehydrogenase in athyreotic rats.
Endocrinology
112:
1732–1738,
1983.
|
86. |
Mason, S. A., and
P. R. Housley.
Site‐directed mutagenesis of the phosphorylation sites in the mouse glucocorticoid receptor.
J. Biol. Chem.
268:
21501–21504,
1993.
|
87. |
Miyamoto, T.,
S. Suzuki, and
L. J. DeGroot.
High affinity and specificity of dimeric binding of thyroid hormone receptors to DNA and their ligand‐dependent dissociation.
Mol. Endocrinol.
7:
224–231,
1993.
|
88. |
Murray, G. R.
Note on the treatment of myxoedema by hypodermic injections of an extract of the thyroid gland of a sheep.
Br. Med. J.
2:
796–797,
1891.
|
89. |
Nagaya, T., and
J. L. Jameson.
Distinct dimerization domains provide antagonist pathways for thyroid hormone receptor action.
J. Biol. Chem.
268:
24278–24282,
1993.
|
90. |
Nagy, L.,
H. Y. Kao,
D. Chakravarti,
R. J. Lin,
C. A. Hassig,
D. E. Ayer,
S. L. Schreiber, and
R. M. Evans.
Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase.
Cell
89:
373–380,
1997.
|
91. |
Nawaz, Z.,
M. J. Tsai, and
B. W. O'Malley.
Specific mutations in the ligand binding domain selectively abolish the silencing function of human thyroid hormone receptor β.
Proc. Natl. Acad. Sci. USA
92:
11691–11695,
1995.
|
92. |
O'Donnell, A. L.,
E. D. Rosen,
D. S. Darling, and
R. J. Koenig.
Thyroid hormone receptor mutations that interfere with transcriptional activation also interfere with receptor interaction with a nuclear protein.
Mol. Endocrinol.
5:
94–99,
1991.
|
93. |
Olson, D. P., and
R. J. Koenig.
5′flanking sequences in thyroid hormone response element half sites determine the requirement of RXR for receptor mediated gene expression.
J. Biol. Chem.
272:
9907–9914,
1997.
|
94. |
Oñate, S. A.,
S. Y. Tsai,
M. Tsai, and
B. W. O'Malley.
Sequence and characterization of a coactivator for the steroid hormone receptor superfamily.
Science
270:
1354–1357,
1995.
|
95. |
Oppenheimer, J. H.,
D. Koerner,
H. L. Schwartz, and
M. I. Surks.
Specific nuclear triiodothyronine binding sites in rat liver and kidney.
J. Clin. Endocrinol. Metab.
35:
330–333,
1972.
|
96. |
Oppenheimer, J. H.,
H. L. Schwartz, and
M. I. Surks.
Tissue differences in the concentration of triiodothyronine nuclear binding sites in rat: liver, kidney, pituitary, heart, brain, spleen and testis.
Endocrinology
95:
897–903,
1974.
|
97. |
Pascual, A.,
J. Casanova, and
H. H. Samuels.
Photoaffinity labeling of thyroid hormone nuclear receptors in intact cells.
J. Biol. Chem.
257:
9640–9647,
1982.
|
98. |
Perlmann, T.,
P. N. Rangarajan,
K. Umesono, and
R. M. Evans.
Determinants for selective RAR and TR recognition of direct repeat HREs.
Genes Dev.
7:
1411–1422,
1993.
|
99. |
Piedrafita, F. J.,
I. Bendik,
M. A. Ortiz, and
M. Pfahl.
Thyroid hormone receptor homodimers can function as ligand‐sensitive repressors.
Mol. Endocrinol.
9:
563–578,
1995.
|
100. |
Prost, E.,
R. J. Koenig,
D. D. Moore,
P. R. Larsen, and
R. G. Whalen.
Multiple sequences encoding potential thyroid hormone receptors isolated from mouse skeletal muscle cDNA libraries.
Nucleic Acids Res.
16:
6248,
1988.
|
101. |
Qi, J.‐ S.,
V. Desai‐Yajnik,
M. E. Greene,
B. M. Raaka, and
H. H. Samuels.
The ligand‐binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation.
Mol. Cell. Biol.
15:
1817–1825,
1995.
|
102. |
Rahman, A.,
A. Esmaili, and
F. Saatcioglu.
A unique thyroid hormone response element in the human immunodeficiency virus type 1 long terminal repeat that overlaps the Sp1 binding sites.
J. Biol. Chem.
270:
31059–31064,
1995.
|
103. |
Rastinejad, F.,
T. Perlmann,
R. M. Evans, and
P. B. Sigler.
Structural determinants of nuclear receptor assembly on DNA direct repeats.
Nature
375:
203–211,
1995.
|
104. |
Refetoff, S.,
R. E. Weiss, and
S. J. Usala.
The syndromes of resistance to thyroid hormone.
Endocr. Rev.
14:
348–399,
1993.
|
105. |
Renaud, J. P.,
N. Rochel,
M. Ruff,
V. Vivat,
P. Chambon,
H. Gronemeyer, and
D. Moras.
Crystal structure of the RAR‐gamma ligand‐binding domain bound to all‐trans retinoic acid.
Nature
378:
681–689,
1995.
|
106. |
Reverdin, J. L., and
A. Reverdin.
Note sur vingtdeux operations de goitre.
Rev. Med. Suisse Romande
3:
169,
1883.
|
107. |
Ribeiro, R.C.J.,
P.J. Kushner, and
J. D. Baxter.
The nuclear hormone receptor gene superfamily.
Annu. Rev. Med.
46:
443–453,
1995.
|
108. |
Roche, J.,
S. Lissitzky, and
R. Michel.
Sur la presence de triiodothyronine dans la thyroglobuline.
Compt. Rend. Acad. Sci.
234:
1228–1230,
1952.
|
109. |
Rohrer, A.
Vergleich des Sauerstoffverbrauchs überlebender Säugetierorgane im normalen Zustande und nach Fütterung mit Schilddrüsenhormon.
Biochem.
145:
154–167,
1924.
|
110. |
Rosen, E. D.,
E. G. Beninghof, and
R. J. Koenig.
Dimerization interfaces of thyroid hormone, retinoic acid, vitamin D and retinoid X receptors.
J. Biol. Chem.
268:
11534–11541,
1993.
|
111. |
Saatcioglu, F.,
T. Deng, and
M. Karin.
A novel cis element mediating ligand independent activation by c‐erbA: implications for hormonal regulation.
Cell
75:
1095–1105,
1993.
|
112. |
Sakurai, A.,
A. Nakai, and
L. J. DeGroot.
Expression of three forms of thyroid hormone receptor in human tissues.
Mol. Endocrinol.
3:
392–399,
1989.
|
113. |
Samuels, H. H., and
J. S. Tsai.
Thyroid hormone action in cell culture: demonstration of nuclear receptors in intact cells and isolated nuclei.
Proc. Natl. Acad. Sci. USA
70:
3488–3492,
1973.
|
114. |
Sanchez‐Pacheco, A.,
T. Palomino, and
A. Aranda.
Negative regulation of expression of the pituitary‐specific transcription factor GHF‐1/Pit‐1 by thyroid hormones through interference with promoter enhancer elements.
Mol. Cell. Biol.
15:
6322–6330,
1995.
|
115. |
Sap, J.,
A. Munoz,
K. Damm,
Y. Goldberg,
J. Ghysdael,
A. Leutz,
H. Beug, and
B. Vennstrom.
The c‐erb‐A protein is a high‐affinity receptor for thyroid hormone.
Nature
324:
635–640,
1986.
|
116. |
Schneider, M. J., and
V. A. Galton.
Rana catesbeiana tadpole red blood cells express an alpha, but not a beta, c‐erbA. gene.
Endocrinology
133:
2488–2495,
1993.
|
117. |
Schwartz, H. L.,
M. A. Lazar, and
J. H. Oppenheimer.
Widespread distribution of immunoreactive thyroid hormone beta2 receptor (TRbeta2) in the nuclei of extrapituitary rat tissues.
J. Biol. Chem.
269:
24777–24782,
1994.
|
118. |
Sharif, M., and
M. L. Privalsky.
v‐erbA oncogene function in neoplasia correlates with its ability to repress retinoic acid receptor action.
Cell
66:
885–893,
1991.
|
119. |
Shupnik, M. A.,
W. W. Chin,
J. F. Habener, and
E. C. Ridgway.
Transcriptional regulation of the thyrotropin subunit genes by thyroid hormone.
J. Biol. Chem.
260:
2900–2903,
1985.
|
120. |
Smith, C. L.,
Z. Nawaz, and
B. W. O'Malley.
Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4–hydroxytamoxifen.
Mol. Endocrinol.
11:
657–666,
1997.
|
121. |
Strait, K. A.,
L. Zou, and
J. H. Oppenheimer.
β1 isoform‐specific regulation of a triiodothyronine‐induced gene during cerebellar development.
Mol. Endocrinol.
6:
1874–1880,
1992.
|
122. |
Sugawara, A.,
P. M. Yen,
J. W. Apriletti,
R.C.J. Ribeiro,
D. B. Sacks,
J. D. Baxter, and
W. W. Chin.
Phosphorylation selectively increases triiodothyronine receptor homodimer binding to DNA.
J. Biol. Chetn.
269:
433–437,
1994.
|
123. |
Tagami, T., and
J. L. Jameson.
Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormone.
Endocrinology
139:
640–650,
1998.
|
124. |
Takeda, K.,
A. Sakurai,
L. J. Degroot, and
S. Refetoff.
Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein‐coding region of the thyroid hormone receptor‐beta gene.
J. Clin. Endocrinol. Metab.
74:
49–55,
1992.
|
125. |
Tata, J. R.,
L. Ernster,
O. Lindberg,
E.S.P. Arrhenius, and
R. Hedman.
The action of thyroid hormones at the cell level.
Biochem. J.
86:
408–428,
1963.
|
126. |
Tata, J. R., and
C. C. Widnell.
Ribonucleic acid synthesis during the early action of thyroid hormones.
Biochem. J.
98:
604–620,
1966.
|
127. |
Taurog, A.,
A. D. Dunn, and
J. T. Dunn.
Hormone synthesis and secretion.
In: Werner and Ingbar's The Thyroid,
7th ed.,
edited by L. E. Braverman and
R. D. Utiger.
Philadelphia:
Lippincott‐Raven,
1996,
p. 47–95.
|
128. |
Thompson, C. C., and
R. M. Evans.
Trans‐activation by thyroid hormone receptors: functional parallels with steroid hormone receptors.
Proc. Natl. Acad. Sci. USA
86:
3494–3498,
1989.
|
129. |
Thompson, C. C.,
C. Weinberger,
R. Lebo, and
R. M. Evans.
Identification of a novel thyroid hormone receptor expressed in the mammalian central nervous system.
Science
237:
1610–1614,
1987.
|
130. |
Tomic‐Canic, M.,
D. Day,
H. H. Samuels,
I. M. Freedberg, and
M. Blumenberg.
Novel regulation of keratin gene expression by thyroid hormone and retinoid receptors.
J. Biol. Chem.
271:
1416–1423,
1996.
|
131. |
Treuter, E.,
T. Albrektsen,
L. Johansson,
J. Leers, and
J.‐A. Gustafsson.
A regulatory role for RIP140 in nuclear receptor activation.
Mol. Endocrinol.
12:
864–881,
1998.
|
132. |
Tsai, M., and
B. W. O'Malley.
Molecular mechanisms of action of steroid/thyroid receptor superfamily members.
Annu. Rev. Biochem.
63:
451–486,
1994.
|
133. |
Umesono, K., and
R. M. Evans.
Determinants of target gene specificity for steroid/thyroid hormone receptors.
Cell
57:
1139–1146,
1989.
|
134. |
Usala, S. J.,
F. E. Wondisford,
T. L. Watson,
J. B. Menke, and
B. D. Weintraub.
Thyroid hormone and DNA binding properties of a mutant c‐erbAβ receptor associated with generalized thyroid hormone resistance.
Biochem. Biophys. Res. Commun.
171:
575–580,
1990.
|
135. |
Vennstrom, B.,
H. Beug,
K. Damm,
D. Engel,
U. Gehring,
T. Graf,
A. Munoz,
J. Sap, and
M. Zenke.
Biological effects of the v‐erbA oncogene in transformation of avian erythroid cells.
In: Molecular Biological Approaches to Thyroid Research,
edited by U. Loos and
L. Wartofsky.
New York:
Thieme Medical Publishers,
1987,
p. 14–19.
|
136. |
Vermeulen, F.
The treatment of myxoedema by feeding with thyroid glands.
Br. Med. J.
1:
226,
1893.
|
137. |
Voegel, J. J.,
M.J.S. Heine,
C. Zechel,
P. Chambon, and
H. Gronemeyer.
TIF2, a 160 kDa transcriptional mediator for the ligand‐dependent activation function AF‐2 of nuclear receptors.
EMBO J.
15:
3667–3675,
1996.
|
138. |
Wagner, R. L.,
J. W. Apriletti,
M. E. McGrath,
B. L. West,
J. D. Baxter, and
R. J. Fletterick.
A structural role for hormone in the thyroid hormone receptor.
Nature
378:
690–697,
1995.
|
139. |
Weinberger, C.,
C. C. Thompson,
E. S. Ong,
R. Lebo,
D. J. Gruol, and
R. M. Evans.
The c‐erb A gene encodes a thyroid hormone receptor.
Nature
324:
641–646,
1986.
|
140. |
Whitfield, G. K.,
J. C. Hsieh,
S. Nakajima,
P. N. MacDonald,
P. D. Thompson,
P. W. Jurutka,
C. A. Haussler, and
M. R. Haussler.
A highly conserved region in the hormone–binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation.
Mol. Endocrinol.
9:
1166–1179,
1995.
|
141. |
Wikström, L.,
C. Johansson,
C. Saltó,
C. Barlow,
A. C. Barros,
F. Bass,
D. Forrest,
P. Thorén, and
B. Vennström.
Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor α1.
EMBO J.
17:
455–461,
1998.
|
142. |
Williams, G. R.,
J. W. Harney,
B. M. Forman,
H. H. Samuels, and
G. A. Brent.
Oligomeric binding of T3 receptor is required for maximal T3 response.
J. Biol. Chem.
266:
19636–19644,
1991.
|
143. |
Williams, G. R.,
A. M. Zavacki,
J. W. Harney, and
G. A. Brent.
Thyroid hormone receptor binds with unique properties to response elements that contain hexamer domains in an inverted palindrome arrangement.
Endocrinology
134:
1888–1896,
1994.
|
144. |
Wilson, T. E.,
T. J. Fahrner, and
J. Milbrandt.
The orphan receptors NGFI‐B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor‐DNA interaction.
Mol. Cell. Biol.
13:
5794–5804,
1993.
|
145. |
Wondisford, F. E.,
H. J. Steinfelder,
M. Nations, and
S. Radovick.
AP‐1 antagonizes thyroid hormone receptor action on the thyrotropin β‐subunit gene.
J. Biol. Chem.
268:
2749–2754,
1993.
|
146. |
Wong, J.,
D. Patterton,
A. Imhof,
D. Guschin,
Y. B. Shi, and
A. P. Wolffe.
Distinct requirements for chromatin assembly in transcriptional repression by thyroid hormone receptor and his‐tone deacetylase.
EMBO J.
17:
520–543,
1998.
|
147. |
Wood, W. W.,
K. O. Ocran,
D. F. Gordon, and
E. C. Ridgway.
Isolation and characterization of mouse complementary DNAs encoding α and β thyroid hormone receptors from thyrotrope cells: the mouse pituitary‐specific β2 isoform differs at the amino terminus from the corresponding species from rat pituitary tumor cells.
Mol. Endocrinol.
5:
1049–1061,
1991.
|
148. |
Yamano, K.,
K. Araki,
K. Sekikawa, and
Y. Inui.
Cloning of thyroid hormone receptor genes expressed in metamorphosing flounder.
Dev. Genet.
15:
378–382,
1994.
|
149. |
Yamano, K., and
Y. Inui.
cDNA cloning of thyroid hormone receptor beta for the Japanese flounder.
Gen. Comp. Endocrinol.
99:
197–203,
1995.
|
150. |
Yang, X.,
V. V. Ogryzko,
J. Nishikawa,
B. H. Howard, and
Y. Nakatani.
A p300/CBP‐associated factor that competes with the adenoviral oncoprotein E1A.
Nature
382:
319–324,
1996.
|
151. |
Yang, Y.,
M. Burgos‐Trinidad,
Y. Wu, and
R. J. Koenig.
Thyroid hormone receptor variant alpha 2: role of the ninth heptad in DNA binding, heterodimerization with retinoid X receptors and dominant negative activity.
J. Biol. Chem.
271:
28235–28242,
1996.
|
152. |
Yen, P. M.,
D. S. Darling,
R. L. Carter,
M. Forgione,
P. K. Umeda, and
W. W. Chin.
Triiodothyronine (T3) decreases binding to DNA by T3‐receptor homodimers but not receptor‐auxiliary protein heterodimers.
J. Biol. Chem.
267:
3565–3568,
1992.
|
153. |
Yen, P. M.,
A. Sugawara, and
W. W. Chin.
Triiodothyronine (T3) differentially affects T3‐receptor/retinoic acid receptor and T3‐receptor/retinoid X receptor heterodimer binding to DNA.
J. Biol. Chem.
267:
23248–23252,
1992.
|
154. |
Yoh, S. M.,
V.K.K. Chatterjee, and
M. L. Privalsky.
Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional core‐pressors.
Mol. Endocrinol.
11:
470–480,
1997.
|
155. |
Yu, K.,
W. Bayona,
C. B. Kallen,
H. P. Harding,
C. P. Ravera,
G. McMahon,
M. Brown, and
M. A. Lazar.
Differential activation of peroxisome proliferator‐activated receptors by eicosanoids.
J. Biol. Chem.
270:
23975–23983,
1995.
|
156. |
Yu, V. C.,
C. Delsert,
B. Andersen,
J. M. Holloway,
O. V. Devary,
A. M. Naar,
S. Y. Kim,
J. M. Boutin,
C. K. Glass, and
M. G. Rosenfeld.
RXRβ—a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements.
Cell
67:
1251–1266,
1991.
|
157. |
Zavacki, A. M.,
J. W. Harney,
G. A. Brent, and
P. R. Larsen.
Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific.
Mol. Endocrinol.
7:
1319–1330,
1993.
|
158. |
Zhang, X. K.,
B. Hoffmann,
P.B.V. Tran,
G. Graupner, and
M. Pfahl.
Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors.
Nature
355:
441–446,
1992.
|
159. |
Zhang, X.‐ K.,
G. Salbert,
M.‐ O. Lee, and
M. Pfahl.
Mutations that alter ligand‐induced switches and dimerization activities in the retinoid X receptor.
Mol. Cell. Biol.
14:
4311–4323,
1994.
|
160. |
Zhang, X. K.,
K. N. Wills,
M. Husmann,
T. Hermann, and
M. Pfahl.
Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities.
Mol. Cell. Biol.
11:
6016–6025,
1991.
|